Insiders / Dowden Nathan J

Dowden Nathan J

CIK 1873392personinsider
Companies
1
First seen
Mar 3, 2026
Last activity
Mar 11, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Entrada Therapeutics, Inc. · TRDAExecutive198,588234,8596

All securities held

2 positions · latest reported per filing
CompanySecuritySharesAs of
Entrada Therapeutics, Inc.Common Stock198,588Mar 10, 2026
Entrada Therapeutics, Inc.Stock Option (Right to Buy)Derivative83,200Mar 1, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Mar 3, 2026OtherTRDA
Entrada Therapeutics, Inc.
Common Stock
$165.0K-14K
-6.17%
213,598
0.55% of shares
low
Mar 10, 2026SellTRDA
Entrada Therapeutics, Inc.
Common Stock
$155.2K-12K
-5.65%
198,588
0.51% of shares
medium
Mar 2, 2026OtherTRDA
Entrada Therapeutics, Inc.
Common Stock
$84.2K-7K
-3.08%
227,636
0.58% of shares
low
Mar 9, 2026SellTRDA
Entrada Therapeutics, Inc.
Common Stock
$40.6K-3K
-1.46%
210,482
0.54% of shares
low
Mar 1, 2026GrantTRDA
Entrada Therapeutics, Inc.
Common Stock
$0+56K
+31.16%
234,859
0.60% of shares
low
Mar 1, 2026GrantTRDA
Entrada Therapeutics, Inc.
Stock Option (Right to Buy)
+83K
83,200
0.21% of shares
low